Acceleration of academic Alzheimer’s programme

20 October 2017

Anyone, any disease, any target. About 20 years ago, Prof Frank Gunn-Moore, University of St Andrews discovered a protein, which he suspected was involved in the deterioration of the brain that causes dementia. 

Thanks to funding from SULSA, Dr Laura Aitken, postdoc in his group, could develop an HTS-compatible assay which was successfully submitted to ELF. In a recent interview, Laura Aitken and Frank Gunn-Moore, explained how academic groups can accelerate their research in collaboration with the European Lead Factory.

Watch the video here or read Laura Aitken's testimonial.